Integration Between Metabolic Tumour Volume and Metabolic Heterogeneity Predicts Outcome of DLBCL Lymphoma Patients in the Sakk 38/07 Study Cohort

Hematological Oncology - United Kingdom
doi 10.1002/hon.47_2629

Related search